RECURSION PHARMACEUTICALS IN

Ticker: RXRX CUSIP: 75629V104 Class: Common Stock

Bridgefront Capital, LLC's Holding History (CIK: 0001725690)

Note: Option positions (PUT/CALL) are excluded.

Q1 2024
Shares 17,551 Value ($000) $175 Avg Close $11.14 Range $8.68 - $15.74
Q3 2023
Shares 14,490 Value ($000) $111 Avg Close $9.98 Range $6.44 - $16.75
Q1 2023
Shares 14,610 Value ($000) $97 Avg Close $7.93 Range $6.40 - $9.73